Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. A. Shah, R. K. Ramanathan, D. Ilson, J. Randazzo, G. K. Schwartz, A. Tse, D. D’Adamo, A. Levner, M. Capanu, D. P. Kelsen
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3011453685